Website
News25/Ratings8
News · 26 weeks35-29%
2025-10-262026-04-19
Mix1990d
- SEC Filings7(37%)
- Insider5(26%)
- Other3(16%)
- Earnings3(16%)
- Analyst1(5%)
Latest news
25 items- SECSEC Form DEF 14A filed by OrthoPediatrics Corp.DEF 14A - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECSEC Form DEFA14A filed by OrthoPediatrics Corp.DEFA14A - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, April 30, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be av
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare ConferenceWARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference. Event: 25th Annual Needham Virtual Healthcare Conference Format: Fireside ChatDate: Tuesday, April 14, 2026Time: 9:30 am ET An audio webcast of the discussions will be available online at the OrthoPediatrics' investor relations website, http://ir.o
- INSIDERCOO and CFO Hite Fred was granted 77,405 shares and sold $224,129 worth of shares (12,993 units at $17.25), increasing direct ownership by 30% to 277,477 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPres. Trauma & Def. Correction Hauser Joseph W was granted 65,700 shares and sold $148,281 worth of shares (8,596 units at $17.25), increasing direct ownership by 41% to 194,767 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPresident and CEO Bailey David R sold $336,979 worth of shares (19,535 units at $17.25), decreasing direct ownership by 6% to 298,020 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPresident of Scoliosis Odle Gregory A sold $145,469 worth of shares (8,433 units at $17.25) and was granted 47,380 shares, increasing direct ownership by 26% to 187,735 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERGeneral Counsel and Secretary Gerritzen Daniel J was granted 47,380 shares and sold $148,592 worth of shares (8,614 units at $17.25), increasing direct ownership by 35% to 149,533 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- SECSEC Form 144 filed by OrthoPediatrics Corp.144 - ORTHOPEDIATRICS CORP (0001425450) (Subject)
- SECSEC Form 10-K filed by OrthoPediatrics Corp.10-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics to Participate in Upcoming ConferencesWARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences. Event: TD Cowen 46th Annual Health Care Conference Format: Fireside Chat Date: Tuesday, March 3, 2026Time: 1:10 pm ET Event: The Citizens Life Sciences Conference Format: Fireside Chat Date: Tuesday, March 10, 2026Time: 10:10 am ET An audio webcast of the discussions will be available online at the OrthoPediatrics' investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be availabl
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial ResultsRecord full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Highlights Helped over 37,500 children in the fourth quarter 2025 and approximately
- PROrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. Th
- PROrthoPediatrics Announces Expanded Enabling Technology Market OpportunityWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted cochlear implantation for school-aged children. OrthoPediatrics has an existing partnership with iotaMotion to bring its robotic-assisted insertion system, designed to enhance the cochlear implant surgery, to pediatric providers, caregivers, and p
- ANALYSTTD Cowen initiated coverage on OrthoPediatrics with a new price targetTD Cowen initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $23.00
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial GuidanceAchieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the fourth quarter and full year ended December 31, 2025, issued 2026 financial guidance, and provided business updates. Recent Business and Financial Highlights: Helped over 37,500 children in the fourth quarter 2025, with the Company now having helped nearly 1.3 millio
- INSIDERPresident and CEO Bailey David R gifted 1,600 shares, decreasing direct ownership by 0.50% to 317,555 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- ANALYSTCanaccord Genuity initiated coverage on OrthoPediatrics with a new price targetCanaccord Genuity initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $24.00
- PROrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product LaunchesWARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division. Developed in collaboration with globally recognized pediatric hip experts, the PediHip™ Rigid Brace and PediHip™ Modular Abduction System are intended for the treatment of Developmental Dysplasia of the Hip (DDH) and post-operative stabilization in ped